Lower drug prices are a priority for Canadians, but not for the federal government
Once again, the federal minister of health has postponed changes to the Patented Medicine Prices Review Board (PMPRB) regulations for another six months until July 1, 2022.
The Conversation ·
Benzinga
The Conversation
The Hindu
The Economic Times
Al Jazeera
Asharq Al-Awsat
Belfast Live
MarketBeat
Motorsport
StockNews.com
The Times of India
Times Life
